Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety Study of Botulinum Toxin Type-A (Dysport®) in Continent Female Subjects Suffering From Idiopathic Overactive Bladder

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* The subject has a diagnosis of idiopathic overactive bladder, without incontinence.~* The subject has ≥ 3 urgency episodes over the course of the 3 days immediately preceding the Baseline visit.~* The subject has ≥ 24 episodes of micturition over the course of the 3 days immediately preceding the Baseline visit.~Exclusion Criteria:~* Bladder outlet obstruction (on urodynamic assessment).~* Post-Micturition Residual Volume \> 150 ml (ultrasound assessment).~* Evidence of a urinary tract infection at Screening or Baseline in the study.~* Active or history of interstitial cystitis, malignancy of the bladder or urothelial tract, a carcinoma in situ (non malignant melanoma is allowed) bladder and/or kidney stones.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- A - 125 units (Type: EXPERIMENTAL): None
- B - 250 units (Type: EXPERIMENTAL): None
- C - 500 units (Type: EXPERIMENTAL): None
- D (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).